pyrroles has been researched along with T-Cell Lymphoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MP; Ferraldeschi, R; Ferrari, N; Gewinner, C; Jueliger, S; Keer, H; Lyons, J; Munck, J; Saini, H; Sims, MJ; Smyth, T; Ward, G | 1 |
| Huang, S; Li, D; Li, T; Liang, L; Liu, J; Nong, L; Zhang, B; Zheng, Y | 1 |
| Ando, S; Asai, M; Goshima, F; Ito, Y; Kawada, JI; Kimura, H; Murata, T; Sato, Y; Shimizu, N; Suzuki, M; Torii, Y; Watanabe, T | 1 |
| Calvo-Vidal, MN; Cayrol, F; Cerchietti, L; Cremaschi, G; Crescenzo, R; Fernando, TM; Gaudiano, M; Gray, NS; Inghirami, G; Kwiatkowski, N; Marullo, R; Pera, B; Phillip, J; Praditsuktavorn, P; Roman, L; Ruan, J; Takpradit, K; Yang, SN; Zhang, T | 1 |
| Ibrahimova, M; Rihova, B; Studenovsky, M; Ulbrich, K | 1 |
| Allen, GE; Chong, SC; Cutcutache, I; Gan, A; Goh, C; Heng, HL; Koo, GC; Lee, KA; Lim, LC; Lim, ST; Loong, S; Ng, CC; Ong, CK; Ong, WS; Poon, SL; Quek, R; Rajasegaran, V; Rozen, S; Tan, D; Tan, L; Tan, P; Tan, SY; Tang, T; Tao, M; Tay, K; Teh, BT; Yap, SP; Yeoh, KW; Yu, W | 1 |
| Gandhi, V; Ravandi, F | 1 |
| Chander, R; Deorukhkar, AA; Pandey, R; Sainis, KB | 1 |
1 review(s) available for pyrroles and T-Cell Lymphoma
| Article | Year |
|---|---|
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.
Topics: Adult; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxyguanosine; Drug Design; Drug Screening Assays, Antitumor; Drugs, Investigational; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Experimental; Lymphoma, T-Cell; Mice; Neoplasm Proteins; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; T-Lymphocytes | 2006 |
7 other study(ies) available for pyrroles and T-Cell Lymphoma
| Article | Year |
|---|---|
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma.
Topics: Apoptosis; Humans; Immunity; Lymphoma, T-Cell; Morpholines; Neoplasm Recurrence, Local; Piperazines; Pyrroles; Skin Neoplasms | 2021 |
JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.
Topics: Apoptosis; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 3; Lymphoma, T-Cell; Male; Middle Aged; Mutation; Phosphorylation; Piperidines; Positive Regulatory Domain I-Binding Factor 1; Pyrimidines; Pyrroles; STAT3 Transcription Factor | 2019 |
Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Topics: Animals; Apoptosis; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Epstein-Barr Virus Infections; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Janus Kinase 3; Killer Cells, Natural; Lymphocyte Activation; Lymphoma, T-Cell; Mice; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; STAT5 Transcription Factor; T-Lymphocytes; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Chromatin; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Female; Gain of Function Mutation; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lymphoma, T-Cell; Male; Mice; Mice, Inbred NOD; Mice, SCID; Phenylenediamines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Pyrroles; Signal Transduction; STAT3 Transcription Factor; Transcription, Genetic; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |
Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Female; Humans; Lymphoma, T-Cell; Mice; Molecular Structure; Polymethacrylic Acids; Pyrroles; Solubility; Xenograft Model Antitumor Assays | 2011 |
Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; DNA Mutational Analysis; Enzyme Activation; Female; Humans; Janus Kinase 3; Lymphoma, T-Cell; Male; Middle Aged; Mutation; Natural Killer T-Cells; Phosphorylation; Piperidines; Pyrimidines; Pyrroles; RNA Interference; STAT5 Transcription Factor | 2012 |
A novel N-alkylated prodigiosin analogue induced death in tumour cell through apoptosis or necrosis depending upon the cell type.
Topics: Alkenes; Alkylation; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Dactinomycin; Diploidy; DNA Fragmentation; DNA, Neoplasm; Enzyme Inhibitors; Lymphoma, T-Cell; Mice; Necrosis; Prodigiosin; Pyrroles; Rats; Sarcoma 180; Staurosporine; Tetrazolium Salts; Thiazoles | 2008 |